Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) receives approval from … – NYSE Post
By Dr. Matthew Watson
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) receives approval from ... NYSE Post Boston, MA, 07/05/2013 (nysepost) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) recently announced that it obtained approval from the Austin Health Human Research Ethics Committee to commence an open label study for the company's drug on ... Prana Biotechnology, Ltd. ADR (NASDAQ:PRAN) prospects broaden after ...Avauncer Drug Manufacturers Other Stocks Buzz: Allergan, Inc.(NYSE:AGN), DURECT ...Techsonian Prana obtains HREC approval for open-label extension study in Alzheimer's ...Pharmaceutical Business Review |
Uncategorized
Comments Off on Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) receives approval from … – NYSE Post |
July 7th, 2013
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research